Literature DB >> 19443633

Family history of renal disease severity predicts the mutated gene in ADPKD.

Moumita Barua1, Onur Cil, Andrew D Paterson, Kairon Wang, Ning He, Elizabeth Dicks, Patrick Parfrey, York Pei.   

Abstract

Mutations of PKD1 and PKD2 account for 85 and 15% of cases of autosomal dominant polycystic kidney disease (ADPKD), respectively. Clinically, PKD1 is more severe than PKD2, with a median age at ESRD of 53.4 versus 72.7 yr. In this study, we explored whether a family history of renal disease severity predicts the mutated gene in ADPKD. We examined the renal function (estimated GFR and age at ESRD) of 484 affected members from 90 families who had ADPKD and whose underlying genotype was known. We found that the presence of at least one affected family member who developed ESRD at age < or =55 was highly predictive of a PKD1 mutation (positive predictive value 100%; sensitivity 72%). In contrast, the presence of at least one affected family member who continued to have sufficient renal function or developed ESRD at age >70 was highly predictive of a PKD2 mutation (positive predictive value 100%; sensitivity 74%). These data suggest that close attention to the family history of renal disease severity in ADPKD may provide a simple means of predicting the mutated gene, which has prognostic implications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443633      PMCID: PMC2723982          DOI: 10.1681/ASN.2009020162

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  20 in total

1.  Genetic heterogeneity of polycystic kidney disease in Europe.

Authors:  D J Peters; L A Sandkuijl
Journal:  Contrib Nephrol       Date:  1992       Impact factor: 1.580

2.  Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease.

Authors:  Y Pei; A D Paterson; K R Wang; N He; D Hefferton; T Watnick; G G Germino; P Parfrey; S Somlo; P St George-Hyslop
Journal:  Am J Hum Genet       Date:  2001-01-10       Impact factor: 11.025

3.  Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.

Authors:  Riccardo Magistroni; Ning He; Kairong Wang; Robin Andrew; Ann Johnson; Patricia Gabow; Elizabeth Dicks; Patrick Parfrey; Roser Torra; Jose L San-Millan; Eliecer Coto; Marjan Van Dijk; Martijn Breuning; Dorien Peters; Nadja Bogdanova; Giulia Ligabue; Alberto Albertazzi; Nick Hateboer; Kyproula Demetriou; Alkis Pierides; Constantinos Deltas; Peter St George-Hyslop; David Ravine; York Pei
Journal:  J Am Soc Nephrol       Date:  2003-05       Impact factor: 10.121

4.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

5.  Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group.

Authors:  N Hateboer; M A v Dijk; N Bogdanova; E Coto; A K Saggar-Malik; J L San Millan; R Torra; M Breuning; D Ravine
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

6.  Segregation analysis of autosomal dominant polycystic kidney disease.

Authors:  A Dobin; W J Kimberling; W Pettinger; J E Bailey-Wilson; Y Y Shugart; P Gabow
Journal:  Genet Epidemiol       Date:  1993       Impact factor: 2.135

7.  Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980.

Authors:  C G Iglesias; V E Torres; K P Offord; K E Holley; C M Beard; L T Kurland
Journal:  Am J Kidney Dis       Date:  1983-05       Impact factor: 8.860

8.  Polycystic kidney disease re-evaluated: a population-based study.

Authors:  F Davies; G A Coles; P S Harper; A J Williams; C Evans; D Cochlin
Journal:  Q J Med       Date:  1991-06

Review 9.  Polycystic kidney disease.

Authors:  Peter C Harris; Vicente E Torres
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

10.  Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.

Authors:  D Ravine; R N Gibson; R G Walker; L J Sheffield; P Kincaid-Smith; D M Danks
Journal:  Lancet       Date:  1994-04-02       Impact factor: 79.321

View more
  46 in total

1.  Third-hit signaling in renal cyst formation.

Authors:  Thomas Weimbs
Journal:  J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 10.121

Review 2.  Diagnosis and management of childhood polycystic kidney disease.

Authors:  William E Sweeney; Ellis D Avner
Journal:  Pediatr Nephrol       Date:  2010-10-29       Impact factor: 3.714

Review 3.  Molecular diagnostics for autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Sandro Rossetti
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

Review 4.  Autosomal dominant polycystic kidney disease in children.

Authors:  Melissa A Cadnapaphornchai
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

5.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

Review 6.  Diagnosis and screening of autosomal dominant polycystic kidney disease.

Authors:  York Pei; Terry Watnick
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

7.  Autosomal dominant polycystic kidney disease.

Authors:  York Pei; Terry Watnick
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

Review 8.  Renal transplantation in autosomal dominant polycystic kidney disease.

Authors:  Nada Kanaan; Olivier Devuyst; Yves Pirson
Journal:  Nat Rev Nephrol       Date:  2014-06-17       Impact factor: 28.314

Review 9.  New treatments for autosomal dominant polycystic kidney disease.

Authors:  Ming-Yang Chang; Albert C M Ong
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

10.  Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin.

Authors:  Djalila Mekahli; Jean-Paul Decuypere; Eva Sammels; Kirsten Welkenhuyzen; Joost Schoeber; Marie-Pierre Audrezet; Anniek Corvelyn; Georges Dechênes; Albert C M Ong; Martijn J Wilmer; Lambertus van den Heuvel; Geert Bultynck; Jan B Parys; Ludwig Missiaen; Elena Levtchenko; Humbert De Smedt
Journal:  Pflugers Arch       Date:  2013-11-06       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.